FDA flags cold smoked sprats after inspectors found missing botulism controls

The FDA is warning consumers, retailers, wholesalers, restaurants, and food service customers not to eat, sell, or serve any cold smoked sprats sold by D&M Smoked Fish Inc., doing business as Haifa Smoked Fish, Inc. The concern is botulism, a rare but potentially fatal illness caused by toxin from Clostridium botulinum.

Food contaminated with botulinum toxin can look normal, smell normal, and taste normal. That is what makes this alert especially dangerous at the point of sale and in the home kitchen: sensory checks offer no protection.

FDA inspectors found that the firm was producing cold-smoked sprats without the required food safety controls meant to prevent Clostridium botulinum growth and toxin formation. The agency recommended that D&M Smoked Fish recall all cold smoked sprats currently on the market, but the firm declined. FDA then issued the alert to warn of the risk to consumers who may still have the product in refrigerators or freezers.

Why cold-smoked fish can become a botulism hazard

Cold-smoked fish poses a specific microbiologic problem because the process does not rely on the same heat kill that would eliminate dangerous organisms in fully cooked products. In an anaerobic or low-oxygen environment, C. botulinum can thrive if the right controls are absent. Once toxin is present, the public health stakes rise quickly because the illness can progress from subtle neurologic symptoms to respiratory failure.

Sprats may also have a long shelf life when frozen, which extends the window of exposure. A product that appears old, forgotten, or long stored is not necessarily safe; frozen storage does not neutralize toxin already formed before freezing. For that reason, frozen inventory remains relevant to the alert.

The distribution pattern adds another layer of concern. Cold smoked sprats were sold to retailers, restaurants, wholesalers, and food service customers in Connecticut, New Jersey, New York, and Pennsylvania, and product may have reached additional states. Bulk cardboard boxes shipped refrigerated and product sold at seafood counters without labels can make traceability difficult for both consumers and businesses.

One missed control can leave an entire product line unsafe.

Symptoms that require immediate emergency care

Botulism can begin with nausea, vomiting, fatigue, weakness, blurred or double vision, difficulty speaking, voice changes, and difficulty swallowing. The hallmark neurologic pattern is descending paralysis, often starting with the face and moving downward. Dry mouth, constipation, and respiratory distress may follow.

These symptoms are not benign foodborne illness complaints. Botulism is a medical emergency, and severe cases can be fatal without intensive care. Early recognition matters because airway compromise and progressive paralysis can develop after what initially seems like a nonspecific gastrointestinal illness.

Anyone who ate the affected sprats and develops neurologic symptoms should seek medical attention immediately. Clinicians need to consider botulism early when a patient presents with cranial nerve findings, bulbar weakness, or rapidly worsening weakness after a suspected food exposure.

Product handling, sanitation, and bedside implications

Consumers who are unsure whether sprats in their possession came from Haifa Smoked Fish should throw them away or contact the place of purchase. Retailers, wholesalers, restaurants, and food service operators should not sell or serve the product. Any food-contact surfaces or containers touched by the fish should be carefully cleaned and sanitized to reduce the risk of cross-contamination.

This alert also has practical implications for clinical history-taking. In suspected botulism, the exposure interview needs to be precise: product name, source, whether it was refrigerated or frozen, where it was purchased, and whether anyone else ate the same food. Because toxin exposure can be shared across households or dining groups, one patient may represent the first warning sign for others who ate the same product.

The FDA’s advice is straightforward: if the product cannot be confidently identified as safe and unrelated to Haifa Smoked Fish, it should not be consumed. In a botulism investigation, uncertainty itself is a reason to discard the food.

Inspection findings and the current market risk

The inspection at D&M Smoked Fish in Jamaica, New York, revealed production without required food safety controls to prevent Clostridium botulinum growth and toxin formation. FDA has said it will update the alert as additional information becomes available. The product distribution map currently confirms sales in four states, but the agency warns that distribution may have extended beyond those borders.

For public health responders, this is the kind of food safety failure that requires rapid recognition and clear consumer messaging. Botulism risk does not depend on visible spoilage, and affected food can remain in circulation long after the first warning is issued. That makes proactive removal from commerce and aggressive public communication central to limiting harm.

For clinicians, the case is a reminder that foodborne neurologic illness still turns up in routine practice. A patient with diplopia, dysphagia, or descending weakness after eating refrigerated or frozen smoked fish should trigger immediate consideration of botulism and urgent escalation of care.

The alert also places responsibility on the retail and food service chain. A mislabeled or unlabeled seafood product can move through multiple hands before a problem is detected, and cold-smoked items with long storage life widen the exposure window. In that setting, a single unsafe production process can generate a prolonged public health risk, especially when the firm declines a recall.

The product name, the affected lot status, and the distribution footprint all make this warning actionable now, not later. The next clinical decision point is simple: recognize the exposure, stop use of the product, and treat possible botulism as a medical emergency.


Reporting by Dr. A.R. Athira, MBBS for Medicine World Foundation, with additional data provided by FDA Press Releases.